SCHEMBL7308841

SCHEMBL7308841

CCOC(=O)Cc1csc(NC(=O)C(Cc2ccccc2)NC(=O)OC(C)(C)C)n1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
TP53 P04637 1/20 0.56
HSD17B10 Q99714 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
ALDH1A1 P00352 5/20 0.55
PTPRB P23467 2/20 0.54
NPC1 O15118 1/20 0.54
HTT P42858 1/20 0.54
RAB9A P51151 1/20 0.54
NPSR1 Q6W5P4 1/20 0.53
CTSS P25774 2/20 0.51
CTSL P07711 1/20 0.51
CTSB P07858 1/20 0.51
CTSK P43235 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7308721 0.91 MAPT (0.58) LMNATP53SMN1; SMN2ALDH1A1PTPRB
SCHEMBL7307957 0.90 MME (0.56) ALDH1A1PTPRBCTSSCTSLCTSB
SCHEMBL7303833 0.89 LMNA (0.58) LMNATP53HSD17B10SMN1; SMN2ALDH1A1
SCHEMBL7306211 0.88 CTSS (0.52) PTPRBCTSSCTSLCTSBCTSK
SCHEMBL7305757 0.88 MEN1 (0.63) LMNATP53SMN1; SMN2ALDH1A1PTPRB
SCHEMBL7443382 0.83 TACR1 (0.53) LMNATP53CTSSCTSLCTSB
SCHEMBL27677878 0.82 CTSS (0.57) PTPRBCTSSCTSLCTSBCTSK
SCHEMBL7308749 0.82 LMNA (0.64) LMNATP53HSD17B10SMN1; SMN2ALDH1A1
SCHEMBL3814091 0.82 CTSS (0.57) PTPRBCTSSCTSLCTSBCTSK
SCHEMBL944756 0.81 SMN1; SMN2 (0.73) LMNATP53SMN1; SMN2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0636630-B1 N-heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases ZAMBON SPA (IT) 1999-04-28 EP disclosed
US-5438046-A Enzyme inhibitors ZAMBON GROUP S.P.A. (IT) 1995-08-01 US disclosed
EP-0636630-A1 N-heteroaryl substituted derivatives of propanamide useful in the treatment of cardiovascular diseases ZAMBON GROUP S.p.A. (IT) 1995-02-01 EP disclosed